GUMINSKI, A.; SQUITTIERI, N.; LEAR, J. T. Adverse Events of Special Interest in Patients with Advanced Basal Cell Carcinoma Receiving Sonidegib: Long-Term 42-Month Results from the BOLT Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s67, 2020. DOI: 10.25251/skin.4.supp.66. Disponível em: Acesso em: 18 aug. 2022.